75 G/A Polymorphism of Apolipoprotein A1 Gene Promoter Region in Normal Pregnant Women and Patients With Gestational Diabetes Mellitus

LI Ruoyu, BAI Huai, GUAN Linbo, LIU Xinghui, FAN Ping, ZHOU Mi, WU Yujie, WANG Yufeng, ZHU Zhengting, WANG Guoyu, WANG


To investigate the -75 G/A single-nucleotide polymorphism in the promoter region of apolipoprotein A1 gene (apoA1) and its association with gestational diabetes mellitus (GDM) in pregnant women and to provide references for the exploration in the molecular genetic basis of GDM.Methods A total of 626 GDM patients and 1022 normal pregnant women, ie, the controls, were included in the study. The genotyping of apoA1 -75 G/A polymorphism was performed by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. Total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and glucose (Glu) were measured by enzymatic methods. Plasma insulin (INS) was measured by chemiluminescence immunoassay. The protein levels of apoA1 and apoB were measured by the turbidimetric immunoassay.Results Allele frequencies of G and A were 0.718 and 0.282 in the GDM group and 0.713 and 0.287 in the control group, respectively. Distribution of the genotype frequencies was found to be in Hardy-Weinberg equilibrium in both the GDM and control groups. There was no significant difference in the frequencies of alleles G and A and the genotypes of apoA1 -75 G/A polymorphism between the GDM and the control group (P>0.05). In the GDM group, the carriers with the genotype AA were associated with significantly higher levels of TC, HDL-C, and apoA1 than those with genotypes GG and GA did (all P<0.05). After the GDM patients were divided into obese and non-obese subgroups, the genotype-related apoA1 variation was observed only in obese patients, while the genotype-related TC and HDL-C variations were evident in non-obese patients (P<0.05). In the control group, carriers of genotypes AA and GA had higher systolic blood pressure (SBP) and HDL-C than the carriers of genotype GG did (all P<0.05). Carriers of genotypes AA had significantly lower Glu levels than carriers of genotypes GG and GA did (P<0.05). The control subjects were further divided into subgroups according to their body mass index (BMI). Analysis of the subgroups showed that AA carriers were associated with higher SBP levels in the obese control women only, while lower Glu levels were evident in both obese and non-obese control women.Conclusion These results suggest that -75 G/A polymorphism in the apoA1 gene is not associated with GDM. However, the genetic variation is closed associated with the plasma apoA1, HDL-C, and TC levels in GDM patients and plasma HDL-C, Glu, and SBP levels in the control subjects. The apoA1 variant-associated lipids and SBP variation is BMI dependent in both groups.

Keywords: Apolipoprotein A1 gene,  Diabetes, gestational,  Polymorphism, single nucleotide,  Lipids,  Glucose

Full Text:



No authors. ACOG Practice Bulletin No.190: gestational diabetes mellitus. Obstet Gynecol ,2018,131(2): e49–e64. doi: 10.1097/AOG. 0000000000002501.

ZHANG C, BAO W, RONG Y, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update, 2013,19(4): 376–390. doi: 10.1093/humupd/dmt013.

RYCKMAN K K, SPRACKLEN C N, SMITH C J, et al. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG,2015,122(5): 643–651. doi: 10.1111/1471-0528. 13261.

LΌPEZ-TINOCO C, ROCA M, GARCΊA-VALERO A, et al. Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus. Acta Diabetol,2013,50(2): 201–208. doi: 10.1007/s00592-011-0264-2.

MRIZAK I, ARFA A, FEKIH M, et al. Inflammation and impaired endothelium-dependant vasodilatation in non obese women with gestational diabetes mellitus: preliminary results. Lipids Health Dis,2013, 12: 93. doi: 10.1186/1476-511X-12-93.

ZHU H, LIU Y, BAI H, et al. Apolipoprotein AⅠ gene MspI polymorphism in relation to endogenous hypertriglyc- eridemia in Chinese population. Chin J Arterioscler,2001(4): 332–336. doi: 10.3969/j. issn.1007-3949.2001.04.017.

METZGER B E, GABBE S G, PERSSON B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care,2010,33(3): 676–682. doi: 10.2337/dc09-1848.

ERLICH H A. PCR technology : principles and applications for DNA amplification/Henry A. New York: Stockton, 1989.

ANGOTTI E, MELE E, COSTANZO F, et al. A polymorphism (G->A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem,1994,269(26): 17371–17374. doi: 10.1016/S0021-9258(17)32445-6.

TANG F M, BAI H, GUAN L B, et al. Association between apolipoprotein C-3 Sst Ⅰ polymorphism and serum lipids in patients with gestational diabetes mellitus. J Sichuan Univ (Med Sci),2023,54(5): 156–161. doi: 10.12182/20230960505.

MATTHEWS D R, HOSKER J P, RUDENSKI A S, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia,1985, 28(7): 412–419. doi: 10.1007/BF00280883.

KAMBOH M I, BUNKER C H, ASTON C E, et al. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol,1999,16(2): 205–222. doi: 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.0.CO;2-P.

PAPAZAFIRI P, OGAMI K, RAMJI D P, et al. Promoter elements and factors involved in hepatic transcription of the human ApoA-I gene positive and negative regulators bind to overlapping sites. J Biol Chem, 1991,266(9): 5790–5797. doi: 10.1016/S0021-9258(19)67666-0.

CIVEIRA F, POCOVI M, CENARRO A, et al. Adenine for guanine substitution -78 base pairs 5' to the apolipoprotein (APO) A-I gene: relation with high density lipoprotein cholesterol and APO A-I concentrations. Clin Genet,1993,44(6): 307–312. doi: 10.1111/j.1399-0004.1993.tb03906.x.

SMITH J D, BRINTON E A, BRESLOW J L. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest,1992,89(6): 1796–1800. doi: 10.1172/JCI115783. LARSON I A,

ORDOVAS J M, BARNARD J R, et al. Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels. Clin Genet,2002,61(3): 176–184. doi: 10. 1034/j.1399-0004.2002.610302.x.

XU C F, ANGELICO F, BEN M D, et al. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genetic Epidemiol,1990,10: 113–122. doi: 10.1002/gepi. 1370100204.

LI N, Van der SIJDE M R, BAKKER S J, et al. Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels. Diabetes,2014, 63(9): 3149–3158. doi: 10.2337/db13-1800.

PHILLIPS C M, GOUMIDI L, BERTRAIS S, et al. Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk. Atherosclerosis,2011,214: 408e14. doi: 10.1016/j.atherosclerosis.2010.10. 029.

YIN R X, WU D F, MIAO L, et al. Several Genetic polymorphisms interact with overweight/obesity to influence serum lipid levels. Cardiovasc Diabetol,2012,11: 123. doi: 10.1186/1475-2840-11-123.

LIU S, GUAN L, LIU X H, et al. ATP-binding cassette transporter G1 (ABCG1) polymorphisms in pregnant women with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol,2023,287: 20–28. doi: 10. 1016/j.ejogrb.2023.05.033.Onlineaheadofprint.

YIN R X, WU D F, WU J Z, et al. Interactions of several lipid-related gene polymorphisms and cigarette smoking on blood pressure levels. Int J Biol Sci,2012,8(5): 685–696. doi: 10.7150/ijbs.4401.


  • There are currently no refbacks.